Please use this identifier to cite or link to this item:
Title: The Morquio A Clinical Assessment Program: Baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects
Authors: Harmatz, Paul
Mengel, Karl Eugen
Giugliani, Roberto
Valayannopoulos, Vassili
Lin, Shuan-Pei
Parini, Rossella
Guffon, Nathalie
Burton, Barbara K.
Hendriksz, Christian J.
Mitchell, John
Martins, Ana Maria [UNIFESP]
Jones, Simon
Guelbert, Norberto
Vellodi, Ashok
Hollak, Carla
Slasor, Peter
Decker, Celeste
Childrens Hosp & Res Ctr Oakland
MC Univ Mainz
Univ Fed Rio Grande do Sul
Hop Necker Enfants Malad
Mackay Mem Hosp
Mackay Med Coll
Az Osped S Gerardo
Hop Femme Mere Enfant
Ann & Robert H Lurie Childrens Hosp
Northwestern Univ
Birmingham Childrens Hosp NHS Fdn Trust
McGill Univ
Universidade Federal de São Paulo (UNIFESP)
Univ Manchester
Hosp Ninos Cordoba
Great Ormond St Hosp Sick Children
Univ Amsterdam
Keywords: MPS
Lysosomal storage disorder
Respiratory function
Issue Date: 1-May-2013
Publisher: Elsevier B.V.
Citation: Molecular Genetics and Metabolism. San Diego: Academic Press Inc Elsevier Science, v. 109, n. 1, p. 54-61, 2013.
Abstract: Objectives: the objectives of this study are to quantify endurance and respiratory function and better characterize spectrum of symptoms and biochemical abnormalities in mucopolysaccharidosis IVA subjects.Methods: MorCAP was a multicenter, multinational, cross sectional study amended to be longitudinal in 2011. Each study visit required collection of medical history, clinical assessments, and keratan sulfate (KS) levels.Results: Data from the first visit of 325 subjects (53% female) were available. Mean age was 14.5 years. Mean +/- SD height z-scores were -5.6 +/- 3.1 as determined by the CDC growth charts. Mean +/- SD from the 6-minute-walk-test was 212.6 +/- 1522 m, revealing limitations in functional endurance testing, and 30.0 +/- 24.0 stairs/min for the 3-minute-stair-climb test. Respiratory function showed limitations comparable to MPS VI patients; mean +/- SD was 1.2 +/- 0.9 1 based on forced vital capacity and 34.8 +/- 25.5 l/min based on maximum voluntary ventilation. Mean urinary keratan sulfate (uKS) was elevated for all ages, and negatively correlated with age. Higher uKS correlated with greater clinical impairment based on height z-scores, endurance and respiratory function tests. the MPS Health Assessment Questionnaire reveals impairments in mobility and activities of daily living in comparison to an age-matched control population.Conclusions: MPS IVA is a multisystem disorder with a continuum of clinical presentation. All affected individuals experience significant functional limitations and reduced quality of life. Older patients have more severe exercise and respiratory capacity limitations, and more frequent cardiac pathology illustrating the progressive nature of disease. (C) 2013 Elsevier Inc. All rights reserved.
ISSN: 1096-7192
Other Identifiers:
Appears in Collections:Em verificação - Geral

Files in This Item:
File Description SizeFormat 
WOS000318055100010.pdf798.32 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.